Navigation Links
China Shenghuo Pharmaceutical Reports Financial Results for the Full Year 2011
Date:3/30/2012

lion to the increase of general and administrative expense.

Research and development expenses: Research and development expense for the year ended December 31, 2011 was approximately $0.71 million as compared to approximately $0.66 million for the year ended December 31, 2010. The increase was primarily due to the expenditures in 2011 for the Phase I clinical test of Sh1002 in America which amounted to $303,335.

Net other expense: Net other expense, which includes interest income, subsidy income, interest expense, other income and other expense, was approximately $1.5 million for the year ended December 31, 2011 as compared to approximately $0.1 million for the year ended December 31, 2010, an increase of approximately $1.4 million, or 1323%. The increase was mainly due to less subsidy income from provincial government as compared the same period in 2010 and more interest expenses in the 2011.

Income tax benefit (expense): Income tax benefit was $11,765 for the year ended December 31, 2011 as compared to income tax expense $105,764 for the year ended December 31, 2010. The tax benefit was mainly from medicine segment of the Company and the deferred tax assets benefit from accrued expenses and provisions for inventory.

Net income attributable to stockholders: We achieved a net income attributable to stockholders of approximately $0.1 million for the year ended December 31, 2011 as compared to approximately $1.2 million for the year ended December 31, 2010. The decrease in net income attributable to stockholders was primarily due to the decrease of subsidy income and increase of interest expense.

About China ShenghuoFounded in 1995, China Shenghuo is primarily engaged in the research, development, manufacture, and marketing of Sanchi-based medicinal and pharmaceutical, nutritional supplement and cosmetic pr
'/>"/>

SOURCE China Shenghuo Pharmaceutical
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ThermoGenesis Announces AABB Accreditation for Cord Blood Products Customer in China
2. Anaphore Announces Acquisition of RuiYi in Shanghai China for GPCR Biologics Drug Discovery Platform
3. Fi Asia-China, Hi & Ni China is Ready for Return on June 2012 in Shanghai
4. China Botanic Reports First Quarter Fiscal 2012 Results
5. Medical Device Market in China 2011-2015
6. Compression Therapy Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
7. China Pharma Holdings, Inc. Reports Full Year 2011 Financial Results
8. Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
9. QIAGEN Expands Access to State-of-the-art HPV Screening in China Through Co-marketing Agreement With KingMed Diagnostics
10. EntreMed Initiates Plans for China Office
11. China Kanghui Holdings to Report Fourth Quarter and Full Year 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... R.I. , July 10, 2014 CVS Caremark ... board of directors has approved a quarterly dividend of $0.275 ... dividend is payable on August 1, 2014, to holders of ... CVS Caremark is dedicated to helping people ... pharmacy company in the United States . ...
(Date:1/15/2014)... Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition of ... Size, Share, Growth, Trends And Forecast, 2013 - 2018" ... http://photos.prnewswire.com/prnh/20130307/600769 ) Dental consumables ... to treat dental impairments, for tooth restoration and in ...
(Date:1/15/2014)... Jan. 15, 2014 Massachusetts General Hospital (MGH), ... AMGN ) announced today that they have launched ... new therapeutic targets and develop novel therapies for ... affects millions worldwide. The MGH-Broad-Amgen collaboration brings together ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... NEW YORK, Jan. 12, 2011 InstaCare Corp. ... prescription and non-prescription diagnostics, home testing products for ... direct to patient diabetes programs, and a leading ... technologies, today announced that the company,s Board of ...
... 2011 At the 29th Annual J.P. Morgan Healthcare Conference, ... that based on a preliminary review of 2010 results, it ... more than $3.5 billion compared to 2009. Adjusted cash earnings ... the midpoint of the company,s latest forecast of $3.37 to ...
Cached Medicine Technology:InstaCare Corp. Announces 2011 Genstrip Guidance Report Penned by William Walling, CFA 2Watson Announces Preliminary Financial Performance for FY 2010 2Watson Announces Preliminary Financial Performance for FY 2010 3Watson Announces Preliminary Financial Performance for FY 2010 4
(Date:7/10/2014)... "Mississippi baby" an infant seemingly cured of HIV that was ... HIV infection in The New England Journal of Medicine ... than two years of not taking antiretroviral therapy without evidence ... involved in the case. , "Certainly, this is ... medical staff involved in the child,s care, and the HIV/AIDS ...
(Date:7/10/2014)... For those students looking to bump up their grade ... spending more time in a library or study hall, ... research shows that students who were members of the ... their freshman and sophomore years had higher GPAs than ... that students with memberships stayed in school longer. An ...
(Date:7/10/2014)... of medical imaging far outweigh the risks when children ... The Right Radiation Dose. However, overuse and misuse of ... leading a collaborative effort to ensure a national protocol ... the Journal of Patient Safety , calls for ... Intersociety Accreditation Commission, and the Centers for Medicare & ...
(Date:7/10/2014)... Many studies have shown that more severe illness and ... a secondary respiratory infection after developing influenza. Now, however, ... has determined that if you reverse the order of ... pneumococcus) may actually protect against a bad case of ... bacterial protein pneumolysin, which is described as a bacterial ...
(Date:7/10/2014)... the human brain operates much the same whether active ... a better understanding of schizophrenia, bipolar disorder and other ... million Americans. , In newly published research in the ... at the Center for Molecular and Behavioral Neuroscience, determined ... rest is basically the same as that of a ...
Breaking Medicine News(10 mins):Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:Want a higher GPA in college? Join a gym 2Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2Health News:Bacterial colonization prior to catching the flu may protect against severe illness 2Health News:Working to loosen the grip of severe mental illness 2
... such as high blood sugar and insulin, and low ... predict whether a woman will develop diabetes during a ... the current issue of the American Journal of ... of all women before pregnancy, particularly overweight women, could ...
... at Chicago are the first to use brain imaging ... function in children with pediatric bipolar disorder or attention ... the October issue of the Journal of the ... PBD and ADHD are very severe developmental disorders that ...
... has been the subject of many studies since its ... unclear picture of XMRV,s role in human disease. In ... of The Journal of Infectious Diseases , now ... XMRV and prostate cancer but not other links involving ...
... Nuclear Medicine (SNM) and the Society for Pediatric ... American Guidelines for Radiopharmaceutical Doses for Children. These ... by standardizing doses (based on body weight) for ... The Alliance for Radiation Safety in Pediatric Imaging ...
... HealthDay Reporter , TUESDAY, Oct. 12 (HealthDay News) -- Women ... breast cancer, even if a close relative has had the ... activity, maintaining a healthy weight and drinking alcohol in moderation, ... help protect against breast cancer in postmenopausal women, the researchers ...
... HealthDay Reporter , TUESDAY, Oct. 12 (HealthDay News) -- ... drugs such as Aredia or Zometa to reduce or delay ... the irregular heartbeat known as atrial fibrillation and for a ... of the heart beat chaotically, causing blood to pool and ...
Cached Medicine News:Health News:Metabolic status before pregnancy predicts subsequent gestational diabetes 2Health News:Brain imaging identifies differences in childhood bipolar disorder, ADHD 2Health News:New studies examine links between XMRV and human disease 2Health News:New studies examine links between XMRV and human disease 3Health News:SNM and Image GentlyTM launch initiative to standardize radiation dose in pediatric nuclear medicine 2Health News:SNM and Image GentlyTM launch initiative to standardize radiation dose in pediatric nuclear medicine 3Health News:Three Healthy Habits Cut Breast Cancer Risk, Study Finds 2Health News:Three Healthy Habits Cut Breast Cancer Risk, Study Finds 3Health News:Cancer-Fighting Bone Drugs Might Raise Stroke Risk 2Health News:Cancer-Fighting Bone Drugs Might Raise Stroke Risk 3
Storage temperature: 2 - 8C, linearity: 0 - 25 mg/dL, expected value: male: 3.5 - 7.0 mg/dL and female: 2.5 - 6.0 mg/dL. Available with calibrator and number of test 500....
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
The assay kit is for determination of uric acid in serum or urine. Wavelength: 600 nm. Linear range: up to 80 mg/dL....
Intended for the quantitative determination of uric acid in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 20 mg/dL (1190 mol/L). Single vial, dry powder reagent....
Medicine Products: